LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Heal
Hims & Hers Health is evolving from a telehealth provider into a scalable, global consumer health platform with diversified growth drivers. The Novo Nordisk partnership validates HIMS' platform, but e
Bank of America lowered its 2026 price target for Hims & Hers (NYSE:HIMS) to $21 from $23, citing peer multiple compression and near-term earnings...
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $19.5, denoting a -4.08% move from the preceding trading day.
American Express, KKR, and other financial stocks are trading at multi-year low valuations, and insider buying at KKR suggests the private credit panic may be overdone.
HIMS is broadening its digital-first platform with Labs, hormone therapy and weight-loss programs as it scales personalized care globally.
Shares of Hims and Hers Health, Inc. (NYSE: HIMS - Get Free Report) have been given an average recommendation of "Hold" by the seventeen ratings firms that are covering the stock, Marketbeat Ratings r
SAN FRANCISCO, April 03, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is actively investigating data privacy claims arising from the Hims & Hers, Inc. data breach.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has comme
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Should You Buy Hims Stock Today?

09:43pm, Thursday, 02'nd Apr 2026
Hims & Hers (HIMS 3.53%) has been one of the most volatile stocks in the markets in recent months.
Hims & Hers, the telehealth company that sells weight-loss drugs and sexual health prescriptions, has confirmed a data breach affecting its third-party customer service platform.
LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Heal
HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $18.78, denoting a -3.1% move from the preceding trading day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE